Abiant, Inc. 480 West Center Street, Grayslake, Illinois 60030
Abiant Overview
Abiant is dedicated to accelerating disease diagnosis and therapeutic development through neuroimaging
Abiant designs, conducts, and analyzes neuroimaging studies for pharmaceutical partners to assess drug effects upon the brain. The image data, which can be collected using small numbers of subjects, provides insight to a drug's brain penetration, target interaction, effects upon brain function, and impact upon disease pathology. This information can help to assess drug viability earlier in development, reducing cost, risk, and bottlenecks. More
Drug Evaluation
Using our core image analysis technologies, we are developing diagnostic tests for Alzheimer's Disease and other brain disorders. By combining proprietary image analysis methods with an unparalleled collection of reference data, we are addressing hurdles to the early, accurate identification of disease. Early and accurate prediction is important today given the availability of symptom-deferring drugs, and will become even more vital as promising compounds in development become available. More